Cargando...
Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril
PURPOSE: Angiotensin-converting enzyme (ACE) inhibitors are recommended for patients with chronic kidney disease (CKD) because they slow disease progression. But physicians’ concerns about the risk of hyperkalemia (elevated serum potassium level), a potentially fatal adverse effect, may limit optima...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2010
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3905673/ https://ncbi.nlm.nih.gov/pubmed/20112435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.1923 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|